As lipopolysaccharide (LPS) is closely associated with
sepsis and
other life-threatening conditions, the point-of-care (POC) detection
of LPS is of significant importance to human health. In this work,
we illustrate an electrochemical aptasensor for the POC detection
of low-abundance LPS by utilizing boronate affinity (BA) as a simple,
efficient, and cost-effective amplification strategy. Briefly, the
BA-amplified electrochemical aptasensing of LPS involves the tethering
of the aptamer receptors and the BA-mediated direct decoration of
LPS with redox signal tags. As the polysaccharide chain of LPS contains
hundreds of cis-diol sites, the covalent crosslinking
between the phenylboronic acid group and cis-diol
sites can be harnessed for the site-specific decoration of each LPS
with hundreds of redox signal tags, thereby enabling amplified detection.
As it involves only a single-step operation (∼15 min), the
BA-mediated signal amplification holds the significant advantages
of unrivaled simplicity, rapidness, and cost-effectiveness over the
conventional nanomaterial- and enzyme-based strategies. The BA-amplified
electrochemical aptasensor has been successfully applied to specifically
detect LPS within 45 min, with a detection limit of 0.34 pg/mL. Moreover,
the clinical utility has been validated based on LPS detection in
complex serum samples. As a proof of concept, a portable device has
been developed to showcase the potential applicability of the BA-amplified
electrochemical LPS aptasensor in the POC testing. In view of its
simplicity, rapidness, and cost-effectiveness, the BA-amplified electrochemical
LPS aptasensor holds broad application prospects in the POC testing.